×
About 80,461 results

ALLMedicine™ Gastric Cancer Center

Research & Reviews  39,579 results

LINC00668 cooperated with HuR dependent upregulation of PKN2 to facilitate gastric canc...
https://doi.org/10.1080/15384047.2021.1905138
Cancer Biology & Therapy; Li J, Dong W et. al.

Apr 21st, 2021 - In China, gastric cancer (GC) ranks first in the incidence of all malignant tumors. With high recurrence and distant metastasis, GC has caused considerable mortalities. LncRNA long intergenic non-protein-coding RNA 668 (LINC00668) has been reporte...

Development and validation of a nomogram to predict intraoperative blood transfusion fo...
https://doi.org/10.1111/tme.12777
Transfusion Medicine (Oxford, England); Huang H, Cao M

Apr 21st, 2021 - To construct and validate a nomogram composed of preoperative variables to predict intraoperative blood transfusion for gastric cancer surgery. Intraoperative transfusion for gastric cancer surgery is a common medical procedure that is associated ...

Clinical and immunologic responses to a B-cell epitope vaccine in HER2/neu overexpressi...
https://doi.org/10.1158/1078-0432.CCR-20-3742
Clinical Cancer Research : an Official Journal of the Ame... Wiedermann U, Garner-Spitzer E et. al.

Apr 21st, 2021 - HER2/neu is overexpressed in up to 30% of gastroesophageal adenocarcinomas (GEA) and linked to poor prognosis. Recombinant mAbs to treat HER2/neu-overexpressing cancers are effective with limitations, including resistance and toxicity. Therefore, ...

Musk ketone induces apoptosis of gastric cancer cells via downregulation of sorbin and ...
https://doi.org/10.3892/mmr.2021.12089
Molecular Medicine Reports; An J, Wang H et. al.

Apr 21st, 2021 - Musk ketone exerts antiproliferative effects on several types of cancer, such as lung and breast cancer. However, the effects and underlying mechanisms of action of musk ketone in gastric cancer (GC) are poorly understood. The present study aimed ...

see more →

Guidelines  89 results

Hereditary diffuse gastric cancer: updated clinical practice guidelines.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7116190
The Lancet. Oncology; Blair VR, McLeod M et. al.

Aug 7th, 2020 - Hereditary diffuse gastric cancer (HDGC) is an autosomal dominant cancer syndrome that is characterised by a high prevalence of diffuse gastric cancer and lobular breast cancer. It is largely caused by inactivating germline mutations in the tumour...

Enhertu Impresses in HER2-Positive Gastric Cancer
https://www.medpagetoday.com/meetingcoverage/asco/86766

May 28th, 2020 - Pretreated gastric cancer patients with HER2-positive disease had significantly improved rates of response and survival with trastuzumab deruxtecan (Enhertu) rather than chemotherapy, an open-label phase II trial showed.

Hereditary Cancer Syndromes and Risk Assessment ACOG COMMITTEE OPINION, Number 793
https://journals.lww.com/greenjournal/Fulltext/2019/12000/Hereditary_Cancer_Syndromes_and_Risk_Assessment_.39.aspx
Obstetrics & Gynecology; ACOG

Nov 30th, 2019 - A hereditary cancer syndrome is a genetic predisposition to certain types of cancer, often with onset at an early age, caused by inherited pathogenic variants in one or more genes. Most hereditary cancer syndromes exhibit autosomal dominant inheri...

Hereditary Cancer Syndromes and Risk Assessment: ACOG COMMITTEE OPINION, Number 793.
https://doi.org/10.1097/AOG.0000000000003562
Obstetrics and Gynecology;

Nov 25th, 2019 - A hereditary cancer syndrome is a genetic predisposition to certain types of cancer, often with onset at an early age, caused by inherited pathogenic variants in one or more genes. Most hereditary cancer syndromes exhibit autosomal dominant inheri...

Gastric Cancer Treatment (PDQ®)–Health Professional Version Go to Patient Version
https://www.cancer.gov/types/stomach/hp/stomach-treatment-pdq

Oct 10th, 2019 - Gastric cancer treatment options depend on extent of disease and may include radical surgery, chemotherapy, radiation, and immunotherapy. Get detailed information about the diagnosis, treatment, and prognosis of newly diagnosed and recurrent gastr...

see more →

Drugs  4 results see all →

Clinicaltrials.gov  40,189 results

LINC00668 cooperated with HuR dependent upregulation of PKN2 to facilitate gastric canc...
https://doi.org/10.1080/15384047.2021.1905138
Cancer Biology & Therapy; Li J, Dong W et. al.

Apr 21st, 2021 - In China, gastric cancer (GC) ranks first in the incidence of all malignant tumors. With high recurrence and distant metastasis, GC has caused considerable mortalities. LncRNA long intergenic non-protein-coding RNA 668 (LINC00668) has been reporte...

Development and validation of a nomogram to predict intraoperative blood transfusion fo...
https://doi.org/10.1111/tme.12777
Transfusion Medicine (Oxford, England); Huang H, Cao M

Apr 21st, 2021 - To construct and validate a nomogram composed of preoperative variables to predict intraoperative blood transfusion for gastric cancer surgery. Intraoperative transfusion for gastric cancer surgery is a common medical procedure that is associated ...

Clinical and immunologic responses to a B-cell epitope vaccine in HER2/neu overexpressi...
https://doi.org/10.1158/1078-0432.CCR-20-3742
Clinical Cancer Research : an Official Journal of the Ame... Wiedermann U, Garner-Spitzer E et. al.

Apr 21st, 2021 - HER2/neu is overexpressed in up to 30% of gastroesophageal adenocarcinomas (GEA) and linked to poor prognosis. Recombinant mAbs to treat HER2/neu-overexpressing cancers are effective with limitations, including resistance and toxicity. Therefore, ...

Musk ketone induces apoptosis of gastric cancer cells via downregulation of sorbin and ...
https://doi.org/10.3892/mmr.2021.12089
Molecular Medicine Reports; An J, Wang H et. al.

Apr 21st, 2021 - Musk ketone exerts antiproliferative effects on several types of cancer, such as lung and breast cancer. However, the effects and underlying mechanisms of action of musk ketone in gastric cancer (GC) are poorly understood. The present study aimed ...

see more →

News  597 results

FDA Approves First Immunotherapy as Initial Treatment of Gastric Cancers
https://www.medscape.com/viewarticle/949460

Apr 15th, 2021 - The US Food and Drug Administration (FDA) today approved the immunotherapy nivolumab (Opdivo, Bristol-Myers Squibb) in conjunction with certain chemotherapies for the frontline treatment of advanced or metastatic gastric cancer, gastroesophageal j...

HER2 Results in Gastric Cancer Often Differ Between Labs With Implications for Treatment
https://www.medscape.com/viewarticle/949035

Apr 11th, 2021 - NEW YORK (Reuters Health) - In more than one of five patients with metastatic gastric cancer (mGC), results of human epidermal growth factor receptor-2 (HER2) testing by local and central labs do not align, and this has implications for response t...

Andecaliximab Disappoints in Advanced Gastric Cancer
https://www.medscape.com/viewarticle/947190

Mar 9th, 2021 - Adding andecaliximab (ADX) to first-line treatment with modified oxaliplatin, leucovorin, and fluorouracil (mFOLFOX6) provided no survival benefit in patients with advanced HER2-negative gastric or gastroesophageal junction adenocarcinoma in the p...

Robotic Total Gastrectomy Pricier, but Has Some Advantages Over Traditional Laparoscopic Approach
https://www.medscape.com/viewarticle/945834

Feb 15th, 2021 - NEW YORK (Reuters Health) - In experienced hands, robotic total gastrectomy has advantages for the surgeon and patient, but is costlier than traditional laparoscopic surgery, according to a study from China. The study showed that "in complex, mini...

Better Survival With S-1/Docetaxel in Stage III Gastric Cancer
https://www.medscape.com/viewarticle/944265

Jan 17th, 2021 - A new recommendation for the treatment of patients with gastric cancer has been proposed on the basis of final results from the phase 3 trial GC-07, which showed survival benefit. The trial was conducted by the Japan Clinical Cancer Research Organ...

see more →

Patient Education  3 results see all →